This inventor holds 7 USPTO granted patents and 19 published patent applications and 3 EPO patents. Top assignees: Hummingbird Bioscience Holdings Pte. Ltd., Hummingbird Bioscience Pte. Ltd.. Active years: 2020-2026.
Company Filing History:
4 out of 4 
3 out of 3 Years Active: 2020-2026
Title: Dipti Thakkar: Innovator in Antigen-Binding Molecules
Introduction
Dipti Thakkar is a prominent inventor based in Singapore, known for her significant contributions to the field of biotechnology. With a total of 7 patents, she has made remarkable strides in the development of antigen-binding molecules that have potential applications in therapeutic treatments.
Latest Patents
Among her latest innovations are the VISTA antigen-binding molecules. These molecules are disclosed along with nucleic acids and expression vectors encoding them, as well as compositions and methods utilizing these VISTA antigen-binding molecules. Additionally, she has developed HER3 antigen-binding molecules, which are similarly accompanied by nucleic acids, expression vectors, and methods for their use.
Career Highlights
Dipti has worked with notable companies such as Hummingbird Bioscience Holdings Pte. Ltd. and Hummingbird Bioscience Pte. Ltd. Her work in these organizations has been instrumental in advancing research and development in the field of biotechnology.
Collaborations
She has collaborated with esteemed colleagues, including Jerome Douglas Boyd-Kirkup and Piers Ingram, contributing to a dynamic research environment that fosters innovation.
Conclusion
Dipti Thakkar's work in antigen-binding molecules exemplifies her dedication to advancing biotechnology. Her patents and collaborations highlight her role as a leading inventor in her field.